8 suspended. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Suspended 8 |
| Phase 2 | 1 | Suspended 1 |
Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial Guideline-directed medical therapy (GDMT), Coronary artery bypass grafting (CABG), Percutaneous coronary intervention (PCI). - Coronary Artery Disease, Cognitive Impairment | Phase 3 | Suspended | NYU Langone Health | 1200 | 2026-12-01 | 2026-06-05 |
| Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Placebo, Seralutinib, Generic Dry Powder Inhaler - Pulmonary Hypertension Associated With Interstitial Lung Disease | Phase 3 | Suspended | GB002, Inc. | 480 | 2026-02-01 | 2026-03-19 |
| Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome. Enzastaurin, Placebo - Vascular Ehlers-Danlos Syndrome | Phase 3 | Suspended | Aytu BioPharma, Inc. | 260 | 2025-01-01 | 2024-03-08 |
| The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients Naloxegol, Placebo - Brain Injuries | Phase 3 | Suspended | University Hospital, Brest | 370 | 2022-03-15 | 2026-06-16 |
| Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment Indapamide / Losartan, Hyzaar® - Hypertension | Phase 3 | Suspended | EMS | 636 | 2019-11-27 | 2022-07-27 |
| Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy selective brain cooling by cold saline perfusion, mechanical thrombectomy - Hypothermia, Stroke, Acute | Phase 2 / Phase 3 | Suspended | Capital Medical University | 120 | 2018-02-06 | 2020-08-04 |
| Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma Single ASCT with Thalidomide maintenance - Multiple Myeloma | Phase 3 | Suspended | Shanghai Jiao Tong University School of Medicine | 80 | 2009-05-01 | 2016-05-10 |
| Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina veliflapon (DG-031) - Acute Coronary Syndrome | Phase 3 | Suspended | deCODE genetics | 3450 | 2006-05-01 | 2006-11-29 |
Coronary Artery Disease (2) · Acute Coronary Syndrome (1) · Angina, Unstable (1) · Brain Injuries (1) · Brain Injuries, Traumatic (1) · Cognitive Dysfunction (1) · Coronary Thrombosis (1) · Ehlers-Danlos Syndrome, Type IV (1) · Heart Failure (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Hypothermia (1) · Lung Diseases, Interstitial (1) · Multiple Myeloma (1) · Myocardial Infarction (1)
Cardiovascular Diseases (8) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Coronary Disease (2) · Heart Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Myocardial Ischemia (2)
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (1) · Coronary Artery Bypass (1) · Hydrochlorothiazide (1) · Indapamide (1) · Losartan (1) · Melphalan (1) · Percutaneous Coronary Intervention (1) · enzastaurin (1) · hydrochlorothiazide, losartan drug combination (1) · naloxegol (1)
Aytu BioPharma, Inc. (1) · Capital Medical University (1) · EMS (1) · GB002, Inc. (1) · NYU Langone Health (1) · Shanghai Jiao Tong University School of Medicine (1) · University Hospital, Brest (1) · deCODE genetics (1)
United States (4) · Brazil (2) · China (2) · France (1) · India (1) · Israel (1) · Mexico (1) · Poland (1) · South Korea (1)
Christopher Granger, M.D. (1) · Douglas W Weaver, M.D. (1) · Jiong HU, M.D. (1) · Olivier Huet, PU-PH (1) · Richard Aranda, MD (1) · S. Bangalore, MD (1) · Shaine Morris, M.D.,M.P.H. (1) · Sherene Shalhub, M.D., M.P.H. (1)
2025 (1)